当前位置:首页 > 股票大全 > 科华生物 002022 财务分析

科华生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

科华生物(002022)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入443,303,887.872,428,075,213.951,904,222,528.931,396,475,774.51
营业总成本482,388,247.212,535,414,687.831,880,857,832.491,329,458,524.99
营业利润-24,086,517.68-179,327,353.0879,198,475.64106,193,677.56
利润总额-24,456,542.99-185,608,835.175,266,249.3104,402,252.74
净利润-21,682,586.79-176,985,109.548,569,569.977,803,935.54
其他综合收益-9,052,139.945,095,342.5415,889,170.3523,703,323.59
综合收益总额-30,734,726.73-171,889,766.9664,458,740.25101,507,259.13
科华生物(002022)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计4,142,000,005.654,316,244,225.334,571,937,062.514,993,440,865.85
非流动资产合计2,478,133,217.832,491,495,641.012,466,228,127.262,464,423,443.03
资产总计6,620,133,223.486,807,739,866.347,038,165,189.777,457,864,308.88
流动负债合计817,399,171.28902,918,171.08878,252,349.761,067,283,200.19
非流动负债合计918,736,544.01920,597,769.17935,001,026.9944,623,446.06
负债合计1,736,135,715.291,823,515,940.251,813,253,376.662,011,906,646.25
归属于母公司股东权益合计4,066,476,863.94,172,116,724.64,399,313,346.434,546,506,357.22
股东权益合计4,883,997,508.194,984,223,926.095,224,911,813.115,445,957,662.63
负债和股东权益合计6,620,133,223.486,807,739,866.347,038,165,189.777,457,864,308.88
科华生物(002022)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计451,797,344.652,777,632,117.182,110,280,610.291,455,627,899.9
经营活动现金流出小计595,409,527.153,252,526,903.652,653,634,803.992,047,688,307.48
经营活动产生的现金流量净额-143,612,182.5-474,894,786.47-543,354,193.7-592,060,407.58
投资活动现金流入小计20,806,243.6639,506,303.8522,313,549.3616,259,260.31
投资活动现金流出小计44,044,364.91645,927,530.18603,948,302.31162,215,379.68
投资活动产生的现金流量净额-23,238,121.25-606,421,226.33-581,634,752.95-145,956,119.37
筹资活动现金流入小计22,755,097.32199,565,783.35176,712,457.8108,695,553.63
筹资活动现金流出小计96,516,410.1996,793,593.55695,804,612.47601,324,674.32
筹资活动产生的现金流量净额-73,761,312.78-797,227,810.2-519,092,154.67-492,629,120.69
汇率变动对现金及现金等价物的影响972,592.069,256,401.242,916,651.931,610,354.49
现金及现金等价物净增加额-239,639,024.47-1,869,287,421.76-1,641,164,449.39-1,229,035,293.15
期末现金及现金等价物余额1,376,357,042.591,605,611,963.811,833,734,936.182,245,864,092.42
科华生物002022相关数据
今日股市大盘指数